Skip to main content
Caplight Logo









Helix

Helix

Private
San Mateo, CaliforniaHealthcare & Life Scienceshttps://www.helix.com/

Last Round

Series C

Jun 3, 2021

Total Funding Raised

$383.4M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Helix is a genomics and data analytics company that provides actionable genetic insights and conducts large-scale genetic analysis to enhance patient care and public health decision-making.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Biotechnology, Drug Discovery, Healthcare Analytics

Business Model

B2B

Customer Profile

Data as a Service, Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

population genomicsprecision medicinegenomic sequencingclinico-genomic databasedirect-to-consumer genetic testingDTC genetic testingdrug discoverypolygenic risk scoringclinical genomic integrationdata as a serviceDaaSgenomic data platformbiobankgenomic healthAI-ready datasets

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Helix Comparables

Compare Helix with similar companies based on industry and business-model similarity.

Helix comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Tempus
78%
SOPHiA GENETICS
76%
DNAnexus
76%

Helix Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CJun 3, 2021
GrantJul 31, 2020
Series BMar 1, 2018
Series AAug 18, 2015

Key People

Founding team and executive leadership

James Lu

CEO, Co-Founder, Board Member

Founding Team

Jim Chou

CTO

Executive Team

Sarah Bobulsky

CFO COO

Executive Team

Helix Investors

Notable investors and investment history

Helix investors
InvestorRounds
TemasekSeries B, Series C
NIH RADxGrant
DFJ GrowthSeries B, Series C
Warburg PincusSeries B, Series A, Series C
VenrockSeries B
Kleiner PerkinsSeries B, Series C
Sutter Hill VenturesSeries B, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 7, 2026

    Clinical laboratory has achieved CAP accreditation.

  • May 7, 2026

    Clinical laboratory has received CLIA certification.

Recent news

Latest coverage and updates

  • partners_withSep 24, 2026

    Helix partnered with Databricks Inc. on Sep 24th '26.

  • signs_new_clientSep 21, 2026

    Helix signed new client Pre-Cure on Sep 21st '26.

  • launchesSep 10, 2026

    Helix launched whole exome+ sequencing for patients with rare and unexplained genetic conditions on Sep 10th '26.

  • partners_withJul 8, 2026

    Helix OpCo LLC partnered with Memorial Hermann on Jul 1st '26.

  • partners_withJul 7, 2026

    Helix OpCo LLC partnered with AstraZeneca on Jul 7th '26.

Helix Filings

Explore SEC and related filing metadata, where available.

Helix filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Helix's valuation, stock price, and market status.

Is Helix a public or private company?

Helix is a private company.

What is the current stock price of Helix?

Helix is a private company with no public stock price. No recent secondary market data is available.

How much is Helix worth (valuation)?

Valuation information for Helix is not publicly available.

Can I buy Helix stock?

Helix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Helix's last funding round?

Helix's most recent funding round was Series C on June 3, 2021.

Who are the main investors in Helix?

Key investors in Helix include Temasek, DFJ Growth, Warburg Pincus, Kleiner Perkins.

Will Helix IPO soon?

No public IPO plans have been announced for Helix.

How can I track Helix secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Helix's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Mateo, California
Employee Range211
Year Founded2015
Last FundingJun 3, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?